Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are female
- You are 18 years old or older at the time of signing up
- You have been diagnosed with Stage I, II, or III breast cancer
- Your doctor has recommended chemotherapy as part of your treatment
- You are signing up before your 3rd chemotherapy treatment session
- You speak English
Who may not be able to join:
- You have a known allergy to the drug memantine
- You have had chemotherapy in the past (before your current treatment plan)
- You have severe memory or thinking difficulties, as measured by a specific memory test (confirm with trial site)
- You have had a heart attack in the last 6 months
- You have heart or bone/joint conditions that would prevent you from exercising
- You have a severe mental health condition such as schizophrenia or bipolar disorder
- You currently struggle with alcohol or drug misuse
- You are unable to swallow capsules
- You have significantly reduced kidney function (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zev Nakamura, MD, UNC Lineberger Comprehensive Cancer Center
Phone: +1 984-888-9244
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rates of recruitment; Rates of retention; Rates of adherence; The acceptability of memantine + Get Real and Heel (MEM+EX)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.